A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers
Alexander Pöhler, Michael Antony, Janine Faigle, Gregor Jordan, Roland F Staack, Gregor P Lotz · 2024
Read A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers by Alexander Pöhler, Michael Antony, Janine Faigle, Gregor Jordan, Roland F Staack, Gregor P Lotz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11703356.txt.
Description
Alexander Pöhler and co-authors developed a platform test to measure a class of lab-made drugs in 2024. Early drug work needs fast measures of how much drug is in the body. A shared test helps when custom reagents for each new drug are not yet ready.
Their test targets a common linker, a short glycine-serine chain that joins parts of many multi-part drugs. The test passed checks for accuracy and precision. It measures total drug levels. Tests for blocking by anti-drug antibodies or by free target showed no effect for one drug, but a possible effect for another. The authors advise checking that blocking for each new drug that uses the platform.
Catalog record
| CREATOR | Alexander Pöhler, Michael Antony, Janine Faigle, Gregor Jordan, Roland F Staack, Gregor P Lotz |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |